Viral vectors for gene therapy (Q45889833)

17 December 2017

review article

1 reference

title

Viral vectors for gene therapy (English)

1 reference

17 December 2017

0 references

Robbins PD

1

1 reference

17 December 2017

Ghivizzani SC

series ordinal

2

1 reference

17 December 2017

publication date

1 October 1998

1 reference

17 December 2017

Pharmacology & Therapeutics

published in

1 reference

17 December 2017

volume

80

1 reference

17 December 2017

page(s)

35-47

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Applications of gene therapy to the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Transfer of genes to humans: early lessons and obstacles to success

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Selection and use of ligands for receptor-mediated gene delivery to myogenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Engineering herpes simplex virus vectors for gene transfer to neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Methods for construction of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

The fate of individual myoblasts after transplantation into muscles of DMD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Eradication of tumor growth via biolistic transformation with allogeneic MHC genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Problems and potential for gene therapy in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Replicating viruses as selective cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

New cationic lipid formulations for gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Replication-defective herpes simplex virus vectors for gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Human gene therapy comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Observations of the carrier state in hamsters infected with Leptospira interrogans serotype pomona

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Use of retroviral vectors for gene transfer and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

The basic science of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A humanized system for pharmacologic control of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

AAV as a viral vector for human gene therapy. Generation of recombinant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Adeno-associated virus: integration at a specific chromosomal locus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

A two-component expression system that responds to inflammatory stimuli in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Second-generation adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

Overexpression of the herpes simplex virus type 1 immediate-early regulatory protein, ICP27, is responsible for the aberrant localization of ICP0 and mutant forms of ICP4 in ICP4 mutant virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900020-5

7 January 2021

10.1016/S0163-7258(98)00020-5

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

9804053

1 reference

17 December 2017